Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-11T02:26:49.403Z Has data issue: false hasContentIssue false

Does psychoeducation influence carers' attitudes to treatment of schizophrenia?

Published online by Cambridge University Press:  13 June 2014

Stephen McWilliams
Affiliation:
DETECT Early Intervention in Psychosis Service, 1 Marine Terrace, Dun Laoghaire, Co Dublin, Ireland
Shane Hill
Affiliation:
Cluain Mhuire Service, Stillorgan, Co Dublin, Ireland
Nora Mannion
Affiliation:
Cluain Mhuire Service, Stillorgan, Co Dublin, Ireland
Anthony Kinsella
Affiliation:
DETECT Early Intervention in Psychosis Service, 1 Marine Terrace, Dun Laoghaire, Co Dublin, Ireland
Eadbhard O'Callaghan
Affiliation:
DETECT Early Intervention in Psychosis Service, 1 Marine Terrace, Dun Laoghaire, Co Dublin, Ireland

Abstract

Objective: To measure the impact of a six-week Carer Psychoeducation Program (CPP) on factors that influence attitudes towards treatment among carers and relatives of people suffering from schizophrenia. We also examined which specific attitudes to treatment the CPP had the most effect on.

Method: Between 2002 and 2004, all patients and their relatives continued standard care. During this period, we conducted a historically-controlled open trial, in which 64 relatives completed a 17-item adapted version of the Drug Attitudes Inventory (DAI) before and after the CPP.

Results: Attitudes to treatment improved significantly overall (p < 0.001), an improvement most marked in terms of attitudes to health and illness, attitudes towards the physician and attitudes towards the potentially harmful effects of treatment. No statistically significant improvement was found, however, in attitudes to locus of control or the preventative role of treatment.

Conclusion: A CPP specifically improves family attitudes towards treatment. This finding is clinically important because such attitudes influence adherence which, in turn, influences outcome. The fact that certain attitudes are influenced by the CPP, while others are not, may help to explain the mechanism through which patient outcomes improve.

Type
Brief Reports
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Mueser, KT, McGurk, SR. Schizophrenia. Lancet 2004(06 19); 363(9426): 2063–72. Review.CrossRefGoogle ScholarPubMed
2.Lanzara, D, Cosentino, U, LoMaglio, AM, Lora, A, Nicolo, A, Rossini, MS. Problems of patients with schizophrenic disorders and of their families. Epidemiol Psichiatr Soc 1999; 2: 117–30.CrossRefGoogle Scholar
3.McFarlane, WR, Dixon, L, Lukens, E, Lucksted, A. Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther 2003; 29(2): 223–45.CrossRefGoogle ScholarPubMed
4.Tarrier, N, Lewis, S, Haddock, G, Bentall, R, Drake, R, Kinderman, Pet al.Cognitivebehavioural therapy in first-episode and early schizophrenia. 18-month follow-up randomised controlled trial. Br J Psych 2004; 184:231–9.CrossRefGoogle ScholarPubMed
5.Pekkala, E, Merinder, L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev 2002; (4): CD002831CrossRefGoogle Scholar
6.Cassidy, E, Hill, S, O'Callaghan, E. Efficacy of psychoeducational intervention on improving relatives' knowledge about schizophrenia and reducing rehospitalisation. Eur Psychiatry 2001; 16(8): 446–50.CrossRefGoogle ScholarPubMed
7.The Changing Minds Campaign. Topline Results of Lansdowne Omnibus Survey in the Republic of Ireland (www.irishpsychiatry.com/survey).Google Scholar
8.Jorm, AF, Blewitt, KA, Griffiths, KM, Kitchener, BA, Parslow, RA. Mental health first aid responses of the public: results from an Australian national survey. BMC Psychiatry 2005; 5(1): 9.CrossRefGoogle ScholarPubMed
9.Paccaloni, M, Pozzan, T, Zimmermann, C. Being informed and involved in treatment: what do psychiatric patients think? A review. Epidemiol Psichiatr Soc 2004; 13(4): 270–83.CrossRefGoogle ScholarPubMed
10.ICD-10: Classification of Mental and Behavioural Disorders. World Health Organization 1993.Google Scholar
11.DSM-IV: Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition. American Psychiatric Association 1993.Google Scholar
12.Hogan, TP, Awad, AG, Eastwood, R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983; 13: 177–83.CrossRefGoogle ScholarPubMed
13. GENSTAT, WINDOWS, 8th Ed (2005), VSN International Ltd.Google Scholar
14.O'Donnell, C, Donohoe, G, Sharkey, L, Owens, N, Migone, M, Harries, Ret al.Compliance therapy: a randomized controlled trial in schizophrenia. BMJ 2003; 327(7419): 834.CrossRefGoogle ScholarPubMed
15.Kamali, M, Kelly, BD, Clarke, M, Browne, S, Gervin, M, Kinsella, Aet al.A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry 2006; 21: 2933.CrossRefGoogle ScholarPubMed
16.Angermeyer, MC, Matschinger, H. Have there been any changes in the public's attitudes towards psychiatric treatment? Results from representative population surveys in Germany in the years 1990 and 2001. Acta Psychiat Scand 2005; 111(1): 6873.CrossRefGoogle ScholarPubMed
17.Birchwood, M, Smith, J, Cochrane, R. Specific and non-specific effects of educational intervention for families living with schizophrenia. A comparison of three methods. Brit J Psychiatry 1992; 160: 806–14.CrossRefGoogle ScholarPubMed